Vincenzo Corbo

Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.

Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.

Reporting tumor molecular heterogeneity in histopathological diagnosis.

Whole genomes redefine the mutational landscape of pancreatic cancer.

Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation.

Genomic analyses identify molecular subtypes of pancreatic cancer.

Hypermutation In Pancreatic Cancer.

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

Whole-genome landscape of pancreatic neuroendocrine tumours.

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.

Fhit down-regulation is an early event in pancreatic carcinogenesis.

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.

PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications.

ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance.

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.

Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas.

Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis.

Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.

Preclinical Modelling of PDA: Is Organoid the New Black?

Muscle derangement and alteration of the nutritional machinery in NSCLC.

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around.

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.